Ubiquitination status does not affect Vps34 degradation

被引:2
|
作者
Tang, Jing [1 ]
Sun, Fei [2 ]
Deng, Xiao-Juan [1 ]
Ma, Yuan-Lin [1 ]
Li, Kun-Yi [1 ]
Tang, Ying [1 ]
Chen, Guo-Jun [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, 1 Youyi Rd, Chongqing 400016, Peoples R China
[2] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA
关键词
Alzheimer's disease; Degradation; Ubiquitination; UPS; VPS34; III PHOSPHOINOSITIDE 3-KINASE; AUTOPHAGY; PIK3C3/VPS34; DELETION; SYSTEM; P53;
D O I
10.1016/j.gendis.2019.05.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vps34 (vacuolar protein-sorting 34) plays important role in autophagy and endosomal trafficking. These processes are closely associated protein ubiquitination and degradation. We have hypothesized that Vps34 ubiquitination status would also control its degradation. Here, we report that our results did not support this assumption. In cells transiently transfected with ubiquitin (UB) constructs contained different lysine residues (Ks), Vps34 ubiquitination could occur regardless of the presence of any Ks in UB. However, Vps34 protein levels were not significantly altered in cells transiently transfected with these UB mutants. We further found that Vps34 protein was altered by pharmacological manipulation of E2/E3 activity; yet this effect was not significantly affected by UB overexpression. In vivo experiments revealed that in APP/PS1 mice, an animal model of Alzheimer's disease (AD), although ubiquitination of Vps34 was significantly reduced, Vps34 protein levels remained unchanged. Vps34 indeed was subjected to proteasomal or lysosomal degradation, as prolonged treatment of proteasomal inhibitor MG132 or lysosomal inhibitor chloroquine elevated Vps34 protein levels. We conclude that unlike most of other proteins, Vps34 ubiquitination is not closely associated with its degradation. Copyright (C) 2019, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 50 条
  • [1] FBXL20-mediated Vps34 ubiquitination as a p53 controlled checkpoint in regulating autophagy and receptor degradation
    Xiao, Juan
    Zhang, Tao
    Xu, Daichao
    Wang, Huibing
    Cai, Yu
    Jin, Taijie
    Liu, Min
    Jin, Mingzhi
    Wu, Kejia
    Yuan, Junying
    GENES & DEVELOPMENT, 2015, 29 (02) : 184 - 196
  • [2] Regulation of autophagy by VPS34 branched ubiquitination controls proteostasis and liver metabolism
    Chen, Yu-Hsuan
    Chen, Ruey-Hwa
    MOLECULAR & CELLULAR ONCOLOGY, 2021, 8 (03)
  • [3] Activation Mechanisms of the VPS34 Complexes
    Ohashi, Yohei
    CELLS, 2021, 10 (11)
  • [4] Ironing out VPS34 inhibition
    Marsh, Timothy
    Debnath, Jayanta
    NATURE CELL BIOLOGY, 2015, 17 (01) : 1 - 3
  • [5] VPS34 Complexes in Plants: Untangled Enough?
    Bhati, Kaushal Kumar
    Luong, Ai My
    Batoko, Henri
    TRENDS IN PLANT SCIENCE, 2021, 26 (04) : 303 - 305
  • [6] Aurone derivatives as Vps34 inhibitors that modulate autophagy
    Guodong Li
    Joshua William Boyle
    Chung-Nga Ko
    Wu Zeng
    Vincent Kam Wai Wong
    Jian-Bo Wan
    Philip Wai Hong Chan
    Dik-Lung Ma
    Chung-Hang Leung
    Acta Pharmaceutica Sinica B, 2019, 9 (03) : 537 - 544
  • [7] Aurone derivatives as Vps34 inhibitors that modulate autophagy
    Li, Guodong
    Boyle, Joshua William
    Ko, Chung-Nga
    Zeng, Wu
    Wong, Vincent Kam Wai
    Wan, Jian-Bo
    Chan, Philip Wai Hong
    Ma, Dik-Lung
    Leung, Chung-Hang
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (03) : 537 - 544
  • [8] Auto-ubiquitination of NEDD4-1 Recruits USP13 to Facilitate Autophagy through Deubiquitinating VPS34
    Xie, Weihong
    Jin, Shouheng
    Wu, Yaoxing
    Xian, Huifang
    Tian, Shuo
    Liu, Di-Ao
    Guo, Zhiyong
    Cui, Jun
    CELL REPORTS, 2020, 30 (08): : 2807 - +
  • [9] Firing up the cold tumors by targeting Vps34
    Janji, Bassam
    Hasmim, Meriem
    Parpal, Santiago
    Berchem, Guy
    Noman, Muhammad Zaeem
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [10] Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathy
    Kimura, Hirotaka
    Eguchi, Satoshi
    Sasaki, Junko
    Kuba, Keiji
    Nakanishi, Hiroki
    Takasuga, Shunsuke
    Yamazaki, Masakazu
    Goto, Akiteru
    Watanabe, Hiroyuki
    Itoh, Hiroshi
    Imai, Yumiko
    Suzuki, Akira
    Mizushima, Noboru
    Sasaki, Takehiko
    JCI INSIGHT, 2017, 2 (01):